(R)-N-(6-(3((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)piperidin-1-yl)pyridin-3-yl)acrylamide

ID: ALA4866757

PubChem CID: 164620575

Max Phase: Preclinical

Molecular Formula: C26H26ClN7O

Molecular Weight: 488.00

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C/C=C/C(=O)Nc1ccc(N2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)nc1

Standard InChI:  InChI=1S/C26H26ClN7O/c1-2-6-24(35)31-17-10-11-23(29-13-17)34-12-5-7-18(16-34)32-26-30-15-21(27)25(33-26)20-14-28-22-9-4-3-8-19(20)22/h2-4,6,8-11,13-15,18,28H,5,7,12,16H2,1H3,(H,31,35)(H,30,32,33)/b6-2+/t18-/m1/s1

Standard InChI Key:  KXUXIJQYOMQECK-OBNPVOHOSA-N

Molfile:  

 
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   34.7693  -22.1692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7681  -22.9967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4830  -23.4096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.1995  -22.9962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1967  -22.1656    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.4812  -21.7564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9148  -23.4077    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.6287  -22.9940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3382  -23.4088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0500  -22.9986    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.0529  -22.1731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3379  -21.7596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6199  -22.1714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7636  -23.4127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0560  -23.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1619  -24.4035    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.9690  -24.2325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7499  -23.6885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3006  -23.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0482  -22.3003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2456  -22.1287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6958  -22.7427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9510  -23.5196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0547  -21.7568    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   39.7584  -24.2372    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.4711  -24.6513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1876  -24.2402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1868  -23.4109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4733  -23.0006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9018  -24.6534    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.6167  -24.2415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3309  -24.6547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6175  -23.4164    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.0458  -24.2428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7600  -24.6559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  8  7  1  6
  8  9  1  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 10 14  1  0
 15 19  1  0
 18 16  1  0
 16 17  1  0
 17 15  2  0
  2 15  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
  1 24  1  0
 14 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 14  1  0
 27 30  1  0
 30 31  1  0
 31 32  1  0
 31 33  2  0
 32 34  2  0
 34 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4866757

    ---

Associated Targets(Human)

CDK2 Tchem CDK2/Cyclin A2 (2260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNH Tbio Cyclin-dependent kinase 7/ cyclin H (714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNK Tbio CDK12/Cyclin K (892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK13 Tchem Cyclin-dependent kinase 13/Cyclin-K (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 488.00Molecular Weight (Monoisotopic): 487.1887AlogP: 5.27#Rotatable Bonds: 6
Polar Surface Area: 98.83Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.49CX LogP: 5.07CX LogD: 5.06
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.32Np Likeness Score: -1.47

References

1. Jiang B, Jiang J, Kaltheuner IH, Iniguez AB, Anand K, Ferguson FM, Ficarro SB, Seong BKA, Greifenberg AK, Dust S, Kwiatkowski NP, Marto JA, Stegmaier K, Zhang T, Geyer M, Gray NS..  (2021)  Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma.,  221  [PMID:33945934] [10.1016/j.ejmech.2021.113481]

Source